Oxygen Biotech
Pharmaceuticals - , Prague, Czechia
Oxygen Biotech Employees
Oxygen Biotech Details
Oxygen Biotech is developing BAZE-X1, an effective treatment for the patients with severe COVID-19 (SARS-CoV-2). We follow on from the R&D organization BIOCEV — a joint project of six institutes of the Academy of Sciences of the Czech Republic and two faculties of Charles University in Prague (Faculty of Science and 1st Faculty of Medicine).BAZE-X1 is a patented drug that has „dual-mode" of action:◼︎ antiviral◼︎ immunomodulatoryOur team consists of leading Czech scientists, clinicians, and internationally recognized specialists both in the European Union (EU) and the United States of America (USA).
Oxygen Biotech Technologies
Domain Name Services
Cloudflare DNS
Hosting
CloudFlare Hosting
Other
Mobile Friendly